Printer Friendly

AVECOR CARDIOVASCULAR REPORTS FIRST QUARTER PROFIT

 AVECOR CARDIOVASCULAR REPORTS FIRST QUARTER PROFIT
 MINNEAPOLIS, May 15 /PRNewswire/ -- AVECOR Cardiovascular Inc.


(NASDAQ: AVEC) today reported net income of $36,325, equal to 1 cent per share, for the three months ended March 31, 1992. Net sales for the quarter were $2,768,071. The company, which acquired the Surgical Division of SCIMED Life Systems, Inc., in June of 1991, had no operations in the year-earlier quarter.
 "Sales for the quarter were solid, reflecting increased sales of our blood reservoir products and the new cardioplegia system which reached the market late last year," said Anthony Badolato, president and chief executive officer. "However, we anticipate that our planned increase in research and development, aimed at expanding and improving our product line, will result in losses for the remainder of this year and next."
 AVECOR Cardiovascular Inc., headquartered in Minneapolis, develops, manufactures and markets specialty disposable medical devices for heart/lung bypass surgery and long-term respiratory support. The company's current products include membrane oxygenators, cardiotomy reservoirs and cardioplegia systems.
 AVECOR Cardiovascular Inc.
 Three Months Ended
 March 31, 1992
 Net sales $2,768,071
 Net income 36,325
 Earnings per share $.01
 Common and common equivalent shares
 outstanding 3,322,280
 -0- 5/15/92
 /CONTACT: Curt Swenson of Swenson Falker Eilertsen, 612-371-0000, for AVECOR Cardiovascular or Norm McGibbon of AVECOR Cardiovascular, 612-559-9504/
 (AVEC) CO: AVECOR Cardiovascular Inc. ST: Minnesota IN: MTC SU: ERN


AL -- MN006 -- 0721 05/15/92 11:52 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 15, 1992
Words:241
Previous Article:WETTERAU REPORTS MODEST INCREASES IN SALES, EARNINGS FOR FISCAL YEAR
Next Article:THE LIMITED, INC. WILL HOLD ITS ANNUAL SHAREHOLDERS MEETING
Topics:


Related Articles
AVECOR CARDIOVASCULAR REPORTS SECOND QUARTER RESULTS
AVECOR CARDIOVASCULAR REPORTS SECOND QUARTER RESULTS
AVECOR CARDIOVASCULAR REPORTS THIRD QUARTER RESULTS
AVECOR CARDIOVASCULAR REPORTS FIRST QUARTER RESULTS AND ANNOUNCES SUBMISSION OF NEW OXYGENATOR TO FDA
AVECOR CARDIOVASCULAR REPORTS LOSS NARROWED IN 1ST QUARTER OF 1994
AVECOR CARDIOVASCULAR REPORTS PROFITABLE FIRST QUARTER
AVECOR CARDIOVASCULAR REPORTS THIRD QUARTER GAINS; ARTERIAL FILTER CLEARED FOR MARKETING BY FDA
AVECOR CARDIOVASCULAR REPORTS PROFITABLE 4TH QUARTER
AVECOR CARDIOVASCULAR REPORTS FIRST QUARTER RESULTS
Avecor Cardiovascular Reports 4th Quarter Earnings

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters